Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michael Dzeda"'
Autor:
Charles J. Schneider, Robert L Witt, Adam Raben, Alexandra L. Hanlon, Elizabeth Mauer, Neil Hockstein, Joshua D. Palmer, Michael Dzeda, Jordan S. L. Silberg, Jon Strasser
Publikováno v:
Oral Oncology. 78:102-107
Objectives The objective of this study was to investigate the safety, tolerability and preliminary efficacy of radiotherapy plus cetuximab in high risk CSCC patients. Materials and Methods Patients with high-risk CSCC diagnosed between 2006 and 2013
Publikováno v:
Cureus
As immunotherapy continues to translate to the clinic and is combined with existing modalities, such as radiation therapy, novel treatment response patterns have been observed which complicate conventional clinical assessment and management. Herein,
Autor:
Neil G. Hockstein, David Raben, Michael Dzeda, Tu Dan, Jennifer F. Cormier, Adam Raben, Robert L. Witt, Charles J. Schneider
Publikováno v:
Oral Oncology. 51:616-621
To update the outcomes of an institutional clinical management approach using ipsilateral neck radiotherapy in the treatment of node-positive squamous cell carcinoma of the tonsil with a well-lateralized primary lesion.Between August 2003 and April 2
Autor:
Charles J. Schneider, A.L. Hanlon, Michael Dzeda, Adam Raben, Joshua D. Palmer, J. Strasser, Neil Hockstein
Publikováno v:
Radiotherapy and Oncology. 119:S534
Autor:
Michael Dzeda, Robert L Witt, A.L. Hanlon, Charles J. Schneider, Jon Strasser, Joshua D. Palmer, Elizabeth Mauer, J. Silberg, Neil Hockstein, Adam Raben
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 94:950
Autor:
Jon Strasser, Charles J. Schneider, Joshua D. Palmer, Adam Raben, Alexandra L. Hanlon, Elizabeth A Mauer, Robert L Witt, Neil Hockstein, Michael Dzeda
Publikováno v:
Journal of Clinical Oncology. 33:6038-6038
6038 Background: Locally advanced, high-risk head and neck cutaneous squamous cell carcinomas (CSCC) are typically aggressive. We sought to compare treatment tolerability, disease control and survi...